Similar articles

• Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis.

  Currey HL, Harris J, Mason RM, Woodland J, Beveridge T, Roberts CJ, Vere DW, Dixon AS, Davies J, Owen-Smith B. Currey HL, et al. Br Med J. 1974 Sep 28;3(5934):763-6. doi: 10.1136/bmj.3.5934.763. Br Med J. 1974. PMID: 4606370 Free PMC article. Clinical Trial.
• Controlled, double-blind, comparative studies of disease modifying anti-rheumatic drugs in the treatment of patients with rheumatoid arthritis. A review.

  Halberg P. Halberg P. Dan Med Bull. 1984 Oct;31(5):391-402. Dan Med Bull. 1984. PMID: 6391848 Review. No abstract available.
• Proceedings: A double-blind comparative trial of cyclophosphamide and gold in rheumatoid arthritis.

  Gumpel JM, Hall A, Ansell B. Gumpel JM, et al. Ann Rheum Dis. 1974 Nov;33(6):574. doi: 10.1136/ard.33.6.574-a. Ann Rheum Dis. 1974. PMID: 4613288 Free PMC article. Clinical Trial. No abstract available.
• Do drugs change the course of rheumatoid arthritis?

  Wright V, Amos R. Wright V, et al. Br Med J. 1980 Apr 5;280(6219):964-6. doi: 10.1136/bmj.280.6219.964-a. Br Med J. 1980. PMID: 6106520 Free PMC article. Review. No abstract available.
• Editorial: Gold revalued.

  [No authors listed] [No authors listed] Lancet. 1974 Apr 27;1(7861):789-90. Lancet. 1974. PMID: 4132717 Clinical Trial. No abstract available.